Frontiers in oncology
Cerdanyola del Vallès, Spain. Associate Editor. Cancer Imaging and Image-directed Interventions. Part of a multidisciplinary journal, this section explores the results from clinical and research imaging studies applied to cancer discovery, diagnosis, and treatment.Guohui Cao. Hongtao Zhang. Juan Wang. Frontiers in Oncology. doi 10.3389/fonc.2024.1339955. 304 views. Part of a multidisciplinary journal, this section explores the impact of genetic aberrations in carcinogenesis, as well as in the progression and outcomes of cancer.2 days ago · Guohui Cao. Hongtao Zhang. Juan Wang. Frontiers in Oncology. doi 10.3389/fonc.2024.1339955. 304 views. Part of a multidisciplinary journal, this section explores the impact of genetic aberrations in carcinogenesis, as well as in the progression and outcomes of cancer.
Did you know?
Since then, the development of ICIs represents a paradigm shift in oncology therapy and prompted us to further study the role of ICIs in treatment of patients with BM. The Checkmate 204 trial of dual ICI therapy showed a dramatic intracranial response rate of 57% of BM from melanoma ( 10 ), as did the randomized phase II ABC …This Research Topic in Frontiers in Oncology provides insightful information about the critical role of nanomedicine in addressing the challenges of cancer immunotherapy. Figure 1 Cancer immunotherapy faces a significant challenge in the form of treatment resistance, posing a major hurdle to its effectiveness.May 10, 2024 · Research Topics. This section advances our understanding of thoracic malignancies, namely pleural tumors, thymic malignancies, lung and mediastinal tumors, lung carcinoids, chest wall tumors and tracheal tumors. James L. Gulley. Frontiers in Oncology. doi 10.3389/fonc.2024.1376622. 218 views. Driving the fast-moving field of immunosurveillance, tumor escape and cancer immunotherapy by hosting research, discussion and new hypotheses. Frontiers in Oncology is a broad-scope, multidisciplinary journal covering all areas of cancer research to advance our knowledge of cancer epidemiology to improve diagnosis, therapeutics and ... 1 Introduction. The accuracy of radiotherapy is crucial to its therapeutic effects on patients. Patient-specific QA is an important standard process to identify discrepancies between the dose calculated by a treatment planning system (TPS) and that delivered by the treatment machine (1–3).For two-dimensional (2D) or three-dimensional (3D) …See all (60) Learn more about Research Topics. Part of a multidisciplinary journal, this section explores the development of personalized and tailored approaches to the prevention, diagnosis, and treatment of breast malignancies.Perspective: rethinking therapeutic strategies in oncology. Immuno-oncology has revolutionized cancer care, drug development, the design of clinical trials, standard treatment paradigms, and the evaluation of response to therapy. These are all areas, however, that have not fully incorporated principles of tumor immunology.Yu Zhu. Jixiang Chu. Dan Luo. Hai-Long Dai. Chengde Liao. Frontiers in Oncology. doi 10.3389/fonc.2024.1394708. This section advances our understanding of thoracic malignancies, namely pleural tumors, thymic malignancies, lung and mediastinal tumors, lung carcinoids, chest wall tumors and tracheal tumors.ann chen. University of Houston. Houston, United States. Associate Editor. Cancer Epidemiology and Prevention. Part of a multidisciplinary journal, this section explores new insights into the distribution, etiology, prevention, survivorship, and surveillance of …This section provides broad mechanistic and translational insights into all aspects of cancer and its interaction with components of the tumor-microenvironment.Jing Yang. Xin Li. Rong-Xia Huang. Jian Chen. Frontiers in Oncology. doi 10.3389/fonc.2024.1377486. 161 views. Part of a multidisciplinary journal, this section explores new insights into the distribution, etiology, prevention, survivorship, and surveillance of cancer incidence.Safeguarding peer review to ensure quality at scale. Making scientific research open has never been more important. But for research to be trusted, it must be of the highest quality. Facing an industry-wide rise in fraudulent science, Frontiers has increased its focus on safeguarding quality. PRESS RELEASE.Title proper: Frontiers in oncology. Abbreviated key-title: Front. oncol. Original alphabet of title: Basic roman. Publisher: Lausanne: Frontiers Media S.A., 2011- Dates of …Terms and conditions. Part of a multidisciplinary journal, this section explores new insights into the distribution, etiology, prevention, survivorship, and surveillance of cancer incidence.Alan Chu. Zongwen Liu. Jose Luis Manzano. Frontiers in Oncology. doi 10.3389/fonc.2024.1322116. 783 views. Part of a multidisciplinary journal, this section expands our understanding of molecular and cellular mechanisms involved in skin cancer progression.See all (158) Learn more about Research Topics. Part of a multidisciplinary journal, this section explores all aspects of hematological malignancies, including acute and chronic leukemia, lymphoma and plasma and hematopoietic stem cell disorders.Frontiers works with research institutions, libraries, consortia, and funders to support authors who want to publish in a Frontiers journal. A central invoicing platform removes the burden from authors and helps contribute to the growing number of research articles that are openly available to all. Organizations can become institutional members ... Frontiers requires manuscripts submitted to meet international English language standards to be considered for publication. For authors who would like their manuscript to receive language editing or proofreading to improve the clarity of the manuscript and help highlight their research, we recommend the language-editing services provided by the following external partners. A future TCR-T therapy encompassing multiple innovations is illustrated in Figure 15, as an example of the driving force in the E2E Platform applied across multiple modules to support the goal of developing differentiated, best-in-class TCR-T therapies as new and better treatment options for cancer patients.penelope jayne duerksen-hughes. Loma Linda University. Loma Linda, United States. Associate Editor. Gynecological Oncology. Part of a multidisciplinary journal, this section explores the development of a personalized and tailored approach to the prevention and treatment of gynecologic malignancies.SLAS Discovery (2018) 23 (6):574–84. doi: 10.1177/2472555218766842. Keywords: organoids, precision medicine, treatment response, treatment prediction, cancer, patient-derived. Citation: Verduin M, Hoeben A, De Ruysscher D and Vooijs M (2021) Patient-Derived Cancer Organoids as Predictors of Treatment Response.May 10, 2024 · Marry M. van den Heuvel-Eibrink. Archie Bleyer. Frontiers in Oncology. doi 10.3389/fonc.2024.1336714. 838 views. Part of a multidisciplinary journal, this section publishes quality basic science, translational studies, and clinical trials in the field of pediatric oncology. Cerdanyola del Vallès, Spain. Associate Editor. Cancer Imaging and Image-directed Interventions. Part of a multidisciplinary journal, this section explores the results from clinical and research imaging studies applied to cancer discovery, diagnosis, and treatment.
francesco giovinazzo. Unit of General and Liver Transplant Surgery, Department of Medical and Surgical Sciences, Agostino Gemelli University Polyclinic (IRCCS) Rome, Italy. Specialty Chief Editor. Surgical Oncology.Apr 23, 2024 ... Emerging therapeutic frontiers in cancer: insights into posttranslational modifications of PD-1/PD-L1 and regulatory pathways. Rong Wang ...New Therapeutic Approaches for Pediatric Glioma: Pre-Clinical and Clinical Studies. Mark Atlas. Derek Hanson. Oren Becher. 395 views. This section aims to create an open access, rapid, transparent and interactive exchange of findings for the neuro-oncology and neurosurgical oncology communities.Added 14 August 2012 • Updated 12 January 2024. A peer-reviewed, open access journal in cancer research, clinical oncology, cancer genetics, molecular targets & surgical …
Baohua Hou. Frontiers in Oncology. doi 10.3389/fonc.2024.1332387. 161 views. Part of a multidisciplinary journal, this section focuses on the investigation of tumorigenesis, prevention, early detection and treatment of …Preprint repository name [Preprint] (2008). Available at: https://persistent-url (Accessed March 15, 2018). Part of a multidisciplinary journal, this section explores the development of personalized and tailored approaches to the prevention, diagnosis, and treatment of breast malignancies.Jan 23, 2024 · 3 Department of Pathology and Laboratory Medicine, Brown University Warren Alpert Medical School, Providence, RI, United States. Editorial on the Research Topic. Expert opinions in genitourinary oncology. In the last decade we have seen an explosion in the development of new treatment options, diagnostic tools, and prognostic and predictive ... …
Reader Q&A - also see RECOMMENDED ARTICLES & FAQs. Abbreviation: FRONT ONCOL. ISSN: 2234-943X. eISSN: 2234-943X. Cate. Possible cause: Frontiers' open access policy ensures high visibility and maximum exposure of your.
List of posts by tag Frontiers in OncologyEpigenetic and Metabolic Regulators of Breast Carcinogenesis. Iman Mamdouh Talaat. Maha Mohamed Saber-Ayad. Hauke Busch. Noha Mousaad Elemam. 21,657 views. 14 articles. Part of a multidisciplinary journal, this section explores the development of personalized and tailored approaches to the prevention, diagnosis, and treatment of breast ...Title proper: Frontiers in oncology. Abbreviated key-title: Front. oncol. Original alphabet of title: Basic roman. Publisher: Lausanne: Frontiers Media S.A., 2011- Dates of …
The Impact Factor for Frontiers in Oncology is based on 2,358 citations in 2017 to 296 articles published in 2015 and 2016, and for CiteScore is based on 4,138 citations in 2017 to 930 articles published in 2014, 2015 and 2016. A total of 222 journals are listed in the Oncology category in the 2017 JCR edition, of which 37 are Open Access.Priority will be given to preclinical and translational evaluations of novel targets and functioning of the target specific therapeutics. Submissions should present significant new information on the mechanisms of targetable molecules in cancer development and metastasis and target-specific therapies. Mechanistic studies that use innovative ...
May 10, 2023 · Female breast cancer (BC) has su Frontiers Books allows users to browse, free of charge, through the pages of Frontiers e-books and e-magazines or download the entire pdf. You may also purchase hardcopy issues as well as other academic literature. ... Keywords: head and neck cancer,oncology,methods,CancerIn Vitro Peptide Re-Stimulation (IVS) of the Murine Splenocytes. Fresh splenocytes isolated from vaccinated animals were stimulated with either HAGE 30-mer long peptides, WT1 15-mer long peptides or both, at a concentration of 1μg/mL in the presence of β-mercaptoethanol and 50U/mL mIL-2 for 7 days at 37°C in a 5% (v/v) CO 2 … List of posts by tag Frontiers in OncologyFrontiers in Oncology publishes rigorousl 3 days ago · See all (43) Learn more about Research Topics. This section explores molecular and clinical characteristics of a broad group of malignancies with special interest on the biology and therapeutic strategies for head and neck cancer subtypes. Guohui Cao. Hongtao Zhang. Juan Wang. Frontiers in Oncolo AI refers to the ability of application machines to imitate humans or human brain functions to learn and solve problems ( 13 ). It has been more than 60 years since John McCarthy put forward the concept of AI in 1956. Over the past ten years, AI technology has made explosive progress.The immunogenicity of cancer cells is a new determinant of anti-cancer immunotherapy. In addition to the development of dendritic cell-based vaccines, immune checkpoint inhibitors and adoptive T cell transfer, researchers have begun to pay more attention on the immunobiology of dead cancer cells and their correlation with the success of cancer ... Frontiers in Immuno-Oncology. Print Special Issue A multidisciplinary team (MDT) in oncology is defined as thPediatric Oncology. sergi aranda. National Sep 5, 2022 ... We're addressing the challenge of immune evasion from two angles. Firstly, by finding novel ways to overcome the defensive mechanisms that ...Visitors may also download and forward articles subject to the citation requirements and subject to any fees POR's publisher, Frontiers, may charge for ... 2 days ago · Guohui Cao. Hongtao Zhang. Juan Wang. Frontiers i Here, introducing Frontiers in Oncology: Quarterly Highlights, we feature a collection of carefully selected articles published during the first quarter of 2019 across the different sections. With a record number of papers to choose from, the papers enclosed in this Special Edition highlight some of the recent advances across the different ... Some hardships faced by frontier farmers were a lack of rainfall and dense earth that was difficult to plow, owing to the tough grasses of the Great Plains. The abbreviation of the journal title "Cancer research front[ michael kattan. Cleveland Clinic Lerner ColOptimizing the first-line treatment for metastatic co Integrative oncology becomes a critical component of evidence-informed, patient-centered cancer care, helping patients and their families navigate the ...
